
    
      Healthy subjects will be included to receive one or two doses of SP Shz TIV The study will
      assess the immunogenicity and safety of a single dose (in subjects from 3 years) or two doses
      of SP Shz TIV vaccine given 28 days apart (pediatric population from 6 to 35 months).
    
  